Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - OCULAR THERAPEUTIX, INC | ocul-20191231ex322084e7c.htm |
| EX-32.1 - EX-32.1 - OCULAR THERAPEUTIX, INC | ocul-20191231ex321d31b2b.htm |
| EX-31.2 - EX-31.2 - OCULAR THERAPEUTIX, INC | ocul-20191231ex3128c0659.htm |
| EX-31.1 - EX-31.1 - OCULAR THERAPEUTIX, INC | ocul-20191231ex311a838b5.htm |
| EX-21.1 - EX-21.1 - OCULAR THERAPEUTIX, INC | ocul-20191231ex211da1fd1.htm |
| EX-10.27 - EX-10.27 - OCULAR THERAPEUTIX, INC | ocul-20191231ex1027c39de.htm |
| EX-4.3 - EX-4.3 - OCULAR THERAPEUTIX, INC | ocul-20191231ex43a015860.htm |
| 10-K - 10-K - OCULAR THERAPEUTIX, INC | ocul-20191231x10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-229085 and 333-230659) and Form S-8 (Nos. 333-198240, 333-202886, 333-210059, 333-216622, 333-223513 and 333-230126) of Ocular Therapeutix, Inc. of our report dated March 12, 2020 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/PricewaterhouseCoopers LLP
Boston, Massachusetts
March 12, 2020